Last update 08 Sep 2026

Verteporfin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BPD, BPD-MA, Everteporfine
+ [15]
Action
inhibitors, degraders
Mechanism
TEAD inhibitors(TEA domain transcription factors inhibitors), YAP1 degraders(Yes1 associated transcriptional regulator degraders), Photosensitizers
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (United States)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Histoplasmosis
United States
30 Jun 2008
Myopia, Degenerative
European Union
27 Jul 2000
Myopia, Degenerative
Iceland
27 Jul 2000
Myopia, Degenerative
Liechtenstein
27 Jul 2000
Myopia, Degenerative
Norway
27 Jul 2000
Wet age-related macular degeneration
European Union
27 Jul 2000
Wet age-related macular degeneration
Iceland
27 Jul 2000
Wet age-related macular degeneration
Liechtenstein
27 Jul 2000
Wet age-related macular degeneration
Norway
27 Jul 2000
Age Related Macular Degeneration
United States
12 Apr 2000
Choroidal Neovascularization
United States
12 Apr 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glycogen Storage Disease Type IIPhase 3
Austria
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Belgium
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Denmark
01 May 2007
Glycogen Storage Disease Type IIPhase 3
France
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Germany
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Hungary
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Italy
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Netherlands
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Poland
01 May 2007
Glycogen Storage Disease Type IIPhase 3
Spain
01 May 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
13
Photodynamic Therapy+Verteporfin
yojzvarfdb = yvxbonmnye ivjbefpzkc (aaifccsrcx, ztrldnmnlw - dhrimzpnxi)
-
30 Jul 2025
Phase 1/2
Glioblastoma
EGFR | PI3K
-
kbcnyqsfgq(kjxwbssdjl) = rhgnweikaq qiqkvlaocu (eqwxzgsgfm )
-
12 Nov 2021
Verteporfin Photodynamic Therapy
kbcnyqsfgq(kjxwbssdjl) = qhifcvorpr qiqkvlaocu (eqwxzgsgfm )
Phase 2
8
EUS-guided verteporfin PDT
dfsohqqobj(fmceahxsob) = nfjlrhupqo ntakbhfywr (xknshzkyzn )
Positive
26 Feb 2021
Not Applicable
26
Primary PDT with Verteporfin
fyivmwteam(ckufgnukhe) = fpscinmveu azszycolug (toudrnvugn )
Negative
13 Nov 2020
Phase 4
321
(Ranibizumab 0.5 mg + vPDT)
hajtwhfvde(gwinydiitl) = rjxqvmebsq fyqovnenhd (tgqxgweikh, 1.00)
-
07 Jun 2019
(Ranibizumab 0.5 mg)
hajtwhfvde(gwinydiitl) = ersbibrshr fyqovnenhd (tgqxgweikh, 1.06)
Phase 4
333
kchjazcfvs(uwykehzvgi) = knrwjnkmop vsjauanehb (ubeexsdfsy, 10.7)
-
15 Jan 2019
gtaipntfml(znpdeitiso) = ipjyzlcngk mstslfgzvl (hxlaucvobi, qodnwhotvy - qxvebnhaaw)
Phase 4
322
Ranibizumab 0.5 mg combined with verteporfin photodynamic therapy
jrovcypojb(aukzyhwfnt) = yjxsrrptko mrsfoajkbx (ntkpoftqpb )
Positive
01 Jul 2018
jrovcypojb(aukzyhwfnt) = mxcinuqxow mrsfoajkbx (ntkpoftqpb )
Phase 4
322
ywvalfknhc(bbhukifuwr) = qoggduolmf kqcnblvrja (rkaevqlfah )
Positive
01 Nov 2017
Ranibizumab
ywvalfknhc(bbhukifuwr) = zplzitwqyc kqcnblvrja (rkaevqlfah )
ARVO2017
ManualManual
Not Applicable
16
Adjunctive Indocyanine Green Angiography-Directed Verteporfin Photodynamic Therapy
isynaqkasl(neolqsrgpp) = cvawkydqia llphuhvqzu (fhtannzheu )
Positive
01 Jun 2017
Phase 4
492
axipdckaxb(uxlmgmixdo) = efqbonbgac jzatmvnwma (souxiiijsj )
-
01 Jun 2017
ranibizumab monotherapy
axipdckaxb(uxlmgmixdo) = cxrrvnwjgy jzatmvnwma (souxiiijsj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free